Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy
- PMID: 16825369
- PMCID: PMC1489497
- DOI: 10.1128/JCM.00083-06
Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy
Abstract
Mycobacterium tuberculosis is one of the leading causes of death worldwide, and multidrug-resistant tuberculosis (MDR-TB) is associated with a high case fatality rate. Rapid identification of resistant strains is crucial for the early administration of appropriate therapy, for prevention of development of further resistance, and to curtail the spread of MDR strains. The Genotype MTBDR (Hain Lifescience, Nehren, Germany) is a reverse hybridization line probe assay designed for the rapid detection of rpoB and katG gene mutations in clinical isolates. The ability of this technique to correctly identify resistant and MDR-TB strains was tested on 206 isolates from the Italian drug resistance surveillance system. This panel included the majority of MDR strains isolated in Italy in the past 3 years. The results of the test were compared to conventional drug susceptibility test performed on isolated strains and verified by sequencing the regions of interest of the bacterial genome. The rate of concordance between the results of the MTBDR and those obtained with "in vitro" sensitivity was 91.5% (130 of 142) for rifampin and 67.1% (116 of 173) for isoniazid. We also applied this test directly to a panel of 36 clinical specimens collected from patients with active TB. The MTBDR correctly identified the two cases of MDR-TB included in the panel. These results show that the MTBDR test is useful in the detection and management of tuberculosis when MDR disease is suspected.
Figures


Similar articles
-
Use of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis complex isolates.J Clin Microbiol. 2005 Aug;43(8):3699-703. doi: 10.1128/JCM.43.8.3699-3703.2005. J Clin Microbiol. 2005. PMID: 16081898 Free PMC article.
-
[Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].Mikrobiyol Bul. 2009 Apr;43(2):217-26. Mikrobiyol Bul. 2009. PMID: 19621606 Turkish.
-
Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.J Clin Microbiol. 2007 Aug;45(8):2635-40. doi: 10.1128/JCM.00521-07. Epub 2007 May 30. J Clin Microbiol. 2007. PMID: 17537937 Free PMC article.
-
The management of tuberculosis: epidemiology, resistance and monitoring.Dan Med Bull. 2010 Nov;57(11):B4213. Dan Med Bull. 2010. PMID: 21055374 Review.
-
GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis.Eur Respir J. 2008 Nov;32(5):1165-74. doi: 10.1183/09031936.00061808. Epub 2008 Jul 9. Eur Respir J. 2008. PMID: 18614561
Cited by
-
General and advanced diagnostic tools to detect Mycobacterium tuberculosis and their drug susceptibility: a review.Eur J Clin Microbiol Infect Dis. 2015 May;34(5):851-61. doi: 10.1007/s10096-014-2306-5. Epub 2015 Jan 6. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25560709 Review.
-
Rapid detection of drug-resistant Mycobacterium tuberculosis by Modified MODS assay suitable for resource-poor settings.PLoS Negl Trop Dis. 2024 Jan 4;18(1):e0011852. doi: 10.1371/journal.pntd.0011852. eCollection 2024 Jan. PLoS Negl Trop Dis. 2024. PMID: 38175831 Free PMC article.
-
Analysis of gene mutations associated with isoniazid, rifampicin and ethambutol resistance among Mycobacterium tuberculosis isolates from Ethiopia.BMC Infect Dis. 2012 Feb 10;12:37. doi: 10.1186/1471-2334-12-37. BMC Infect Dis. 2012. PMID: 22325147 Free PMC article.
-
Comprehensive multicenter evaluation of a new line probe assay kit for identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis.J Clin Microbiol. 2012 Mar;50(3):884-90. doi: 10.1128/JCM.05638-11. Epub 2012 Jan 11. J Clin Microbiol. 2012. PMID: 22205814 Free PMC article.
-
Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire.Eur J Microbiol Immunol (Bp). 2014 Sep;4(3):166-73. doi: 10.1556/EUJMI-D-14-00014. Epub 2014 Sep 11. Eur J Microbiol Immunol (Bp). 2014. PMID: 25215193 Free PMC article.
References
-
- Ahmad, S., and E. Mokaddas. 2004. Contribution of AGC to ACC and other mutations at codon 315 of the katG gene in isoniazid-resistant Mycobacterium tuberculosis isolates from the Middle East. Int. J. Antimicrob. Agents 23:473-478. - PubMed
-
- Ahmad, S., and E. Mokaddas. 2005. The occurrence of rare rpoB mutations in rifampicin-resistant clinical Mycobacterium tuberculosis isolates from Kuwait. Int. J. Antimicrob. Agents 26:205-212. - PubMed
-
- Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. S. Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230. - PubMed
-
- Banerjee, A., M. Sugantino, J. C. Sacchettini, and W. R. Jacobs, Jr. 1998. The mabA gene from the inhA operon of Mycobacterium tuberculosis encodes a 3-ketoacyl reductase that fails to confer isoniazid resistance. Microbiology 144(Pt. 10):2697-2704. - PubMed
-
- Bartfai, Z., A. Somoskovi, C. Kodmon, N. Szabo, E. Puskas, L. Kosztolanyi, E. Farago, J. Mester, L. M. Parsons, and M. Salfinger. 2001. Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay. J. Clin. Microbiol. 39:3736-3739. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous